ストックスクリーナーアプリを入手
1.28
0.79%
0.01
アフターアワーズ：
1.27
-0.01
-0.78%
前日終値:
$1.27
開ける：
$1.26
24時間の取引高:
66,982
Relative Volume:
0.69
時価総額：
$43.28M
収益：
-
当期純損益:
$-14.47M
株価収益率:
-1.0323
EPS:
-1.24
ネットキャッシュフロー:
$-12.19M
1週間 パフォーマンス:
+0.79%
1か月 パフォーマンス:
-17.42%
6か月 パフォーマンス:
-40.19%
1年 パフォーマンス:
-54.77%
1日の値動き範囲:
$1.26
$1.33
1週間の範囲:
$1.2001
$1.3499
52週間の値動き範囲:
$1.17
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
BEAT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.28 | 42.94M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
276.46 | 46.02B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.65 | 10.32B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.12 | 8.40B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.60 | 11.28B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
37.06 | 6.51B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-09-11 | 開始されました | Needham | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Neutral |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-08-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-07-26 | 繰り返されました | Lake Street | Buy |
| 2018-04-26 | 繰り返されました | The Benchmark Company | Buy |
| 2018-02-23 | 繰り返されました | Dougherty & Company | Buy |
| 2017-11-08 | 繰り返されました | Dougherty & Company | Buy |
| 2017-10-26 | 開始されました | Raymond James | Outperform |
| 2017-10-24 | 開始されました | SunTrust | Buy |
| 2017-08-09 | 繰り返されました | Dougherty & Company | Buy |
| 2017-07-19 | 繰り返されました | The Benchmark Company | Buy |
| 2017-04-11 | 繰り返されました | Dougherty & Company | Buy |
| 2016-12-02 | 開始されました | Dougherty & Company | Buy |
| 2016-09-13 | 開始されました | Sidoti | Buy |
| 2016-08-03 | 繰り返されました | The Benchmark Company | Buy |
| 2015-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2013-10-24 | 開始されました | The Benchmark Company | Buy |
| 2013-08-21 | 開始されました | Dougherty & Company | Buy |
すべてを表示
Heartbeam Inc (BEAT) 最新ニュース
HeartBeam Holds Virtual Annual Stockholders Meeting - MSN
HeartBeam elects directors and approves equity plan amendment at annual meeting - Investing.com
Why HeartBeam Inc. stock attracts strong analyst attentionFree Stock Market Analysis Courses - Newser
Why HeartBeam Inc. Equity Warrant stock attracts strong analyst attentionSafety First Trading Signals - Newser
What makes HeartBeam Inc. stock price move sharplyInvestor Favorite Picks - Newser
How HeartBeam Inc. stock performs during market volatilityInstant Stock Updates - Newser
How HeartBeam Inc. Equity Warrant stock performs during market volatilityHigh Reward Risk Balanced Trading - Newser
What makes HeartBeam Inc. Equity Warrant stock price move sharplyFree Top-Rated Stock Analysis - Newser
IBN Coverage: HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection - The Globe and Mail
HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology - TipRanks
IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch - Yahoo Finance
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 - Business Wire
BEAT Stock: A Comprehensive Analysis and Forecast - investchronicle.com
HeartBeam Inc. Pioneers Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring - citybuzz -
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG - citybuzz -
HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG - financial-news.co.uk
HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results - citybuzz -
Here's Why HeartBeam (NASDAQ:BEAT) Must Use Its Cash Wisely - Yahoo Finance
HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing
Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India
HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com
HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus
HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer
HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa
Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView
HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria
HeartBeam, Inc. SEC 10-Q Report - TradingView
HeartBeam Reports First Quarter 2025 Results - Business Wire
The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail
HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance
Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com
Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT) - Barchart.com
HeartBeam Secures 2 New U.S. Patents - Medical Product Outsourcing
HeartBeam (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio - Barchart.com
HeartBeam (BEAT) Expands IP Portfolio with New U.S. Patents | BEAT Stock News - GuruFocus
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire
HeartBeam's Game-Changing Patents Transform Cardiac Monitoring with Credit Card-Sized 3D ECG Device - Stock Titan
HeartBeam Expands Board with CEO Robert Eno’s Appointment - citybuzz -
Heartbeam Inc (BEAT) 財務データ
収益
当期純利益
現金流量
EPS
1.25%
0.96%
大文字化:
|
ボリューム (24 時間):